# Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study

> **NCT01824537** · PHASE4 · COMPLETED · sponsor: **McGill University** · enrollment: 372 (actual)

## Conditions studied

- Human Papillomavirus Infection

## Interventions

- **BIOLOGICAL:** HPV vaccine, Gardasil 9
- **BIOLOGICAL:** Hepatitis A vaccine

## Key facts

- **NCT ID:** NCT01824537
- **Lead sponsor:** McGill University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2022-11-18
- **Final completion:** 2022-11-18
- **Target enrollment:** 372 (ACTUAL)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01824537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01824537, "Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01824537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*